Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Mendelics | RCV000012804 | SCV001139372 | pathogenic | Propionic acidemia | 2019-05-28 | criteria provided, single submitter | clinical testing | |
| Invitae | RCV000012804 | SCV001580696 | pathogenic | Propionic acidemia | 2023-05-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects PCCA function (PMID: 10101253). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PCCA protein function. ClinVar contains an entry for this variant (Variation ID: 12024). This variant is also known as M348K. This missense change has been observed in individual(s) with propionic acidemia (PMID: 10101253, 22033733, 33028371). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs121964958, gnomAD 0.0009%). This sequence change replaces methionine, which is neutral and non-polar, with lysine, which is basic and polar, at codon 373 of the PCCA protein (p.Met373Lys). |
| Baylor Genetics | RCV000012804 | SCV004202891 | likely pathogenic | Propionic acidemia | 2023-04-03 | criteria provided, single submitter | clinical testing | |
| OMIM | RCV000012804 | SCV000033044 | pathogenic | Propionic acidemia | 1999-03-30 | no assertion criteria provided | literature only |